The study indicates that each local reagent-instrument combination must be calibrated by the participant to obtain reliable INR values. The use of a general correction factor for a local PT system seems to be invalid owing to the considerable variation in performance of individual coagulometers. The two best guides to the choice of coagulometer may be the deviation from the manual result and precision estimated by the coefficient of variation of the INR. 
The number of centres using automated and semiautomated techniques for the prothrombin time (PT) is steadily increasing in the United Kingdom. According to National External Quality Assessment Scheme (NEQAS) survey returns, by 1988 about 50% of hospitals were using a coagulometer. There have been many changes in procedures since our previous report on automated instruments.' We have therefore limited the analysis to the results of the last two years' NEQAS surveys. This period was chosen because in 1986 there was a major change in methodology in the United Kingdom with the withdrawal of the Manchester Comparative Reagent human brain thromboplastin, and the spectrum of instruments is constantly changing.
Material and methods
Results of the serial NEQAS surveys of the PT between April 1986 and October 1987 were reviewed. These provided a total of 20 test plasmas for inclusion Accepted for publication 4 August 1988 in the study. All samples were from patients receiving anticoagulant treatment with nicoumalone (Sinthrome) and were obtained from single donors by plasmapheresis.
The number of unsatisfactory performers in NEQAS (greater than 15% deviation from the reagent manual mean) for four surveys that is slope < 10-but with three of these (Fibrintimer, Lancer and KC4/10) this tendency was only evident with high INR values. With these three instruments there was a transition from underestimation to overestimation which seemed to take place at the mid therapeutic zone-that is with an INR of about 3 0. This effect was also observed with about two thirds of the KC4/10 users when results from individual laboratories were examined. An example of a centre showing this effect is seen in fig 1. Another laboratory with the same type of instrument gave a more satisfactory correlation (fig 2) . When the effect of a reagent-instrument interaction on log PTs was studied for the KC4/KC1O system, a different slope was observed with the two rabbit thromboplastins-that is, 0 93 for reagent A and 0-86 for reagent B. Tables 3 and 4 give the orthogonal regression slopes obtained at individual centres using the KC4/10 with reagents A and B, respectively, showing the range of variation of the slope obtained from the data ofthe respective laboratories. The slopes of the INR values for individual laboratories with the KC4/10 ranged between 0-80 and 0-96 for reagent A; mean INR value slopes for the whole group of different coagulometers used with reagent A was 0X89-1 01. The within instrument differences were similar to those produced by different coagulometers.
The INR results with coagulometers reported by participants were compared with the corresponding manual mean obtained in the NEQAS surveys (table  5) coagulometers, there were obvious coagulometer effects, with the mean INR ranging from 2-67 to 2-93 for reagent A. The precision estimated by the CV of the INR varied between 6-93 and 12-88 for this reagent. Seven of the eight systems gave less precision than the manual method. In contrast with reagent B, the manual technique gave the largest recorded CV of the INR. The one instrument used in sufficient numbers with this reagent, the KC4/10, improved this result. Discussion Over the past decade an increasing number of United Kingdom laboratories have adopted automated and semiautomated methods for PT testing. By late 1987 almost half the hospitals were using an automated Data from NEQAS surveys had suggested that coagulometers had an individual effect on the INR values. The effect varied according to the routine thromboplastin used. Only one type ofinstrument, the KC4/KCIO, was used in sufficient numbers for analysis with more than one reagent. The different slopes, 0 93 and 0-86, respectively, for reagents A and B confirmed that pooling the data of coagulometer performance over the range of thromboplastins is therefore invalid. This agrees with the published data from the College of American Pathologists' surveys2 and serial reports from the United Kingdom NEQAS surveys. It was therefore considered advisable to restrict the analysis to users of one reagent used by about 75% of United Kingdom centres. To permit reasonable statistical analysis in the present survey the observations were limited to the effects of the eight instruments used by an average of six or more participants with this reagent. Of these, however, only four, KC4/10, Burkard, Coag-a-mate x 2 and Fibrintimer were used by 15 or more laboratories in each survey and therefore more confidence can be placed in their mean results.
Although they differed across the range of instruments, the regression slopes were similar, irrespective of whether they are analysed as PTs or INR. With six of the eight instruments evaluated, the CV of the slope of the INR wag greater than the CV of the slope of the PT. This implies that there was an additional error in the conversion of the PTs to INR, and the international sensitivity index (ISI)/INR system was of no assistance in reducing the coagulometer effects.
With reagent A, the mean slopes showed a degree of variation and they were significantly different from the . There were similar findings with reagent B. This indicates that the local variable with each KC4/10 coagulometer is at least as great as the differences introduced by the range of instruments systems. With some KC4/10 instruments there was a noticeable tendency to overestimate high INR but this was not uniform as some showed a more linear response. The observation suggests that there is a need for adjustment of individual instruments to obtain linearity of INR values. Each coagulometer must be calibrated locally by participants as the use of a correction factor, or adjustment of the ISI for all models of one instrument type, seems to be invalid. A range of plasmas calibrated in INR might assist users of instruments to either correct for the local instrument variable or permit adjustment of the coagulometer to achieve the desired result.
Perhaps the two best rapid guides to the reliability of a coagulometer are its deviation from the manual results and its precision estimated by the CV of the INR for the particular instrument group. Table 5 provides these data and shows that instruments with the best precision do not necessarily give the result which approximates best to the manual method. The choice with the present generation of coagulometers may therefore be a compromise between these parameters. 
